Viewing Study NCT03485950


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2025-12-27 @ 8:26 AM
Study NCT ID: NCT03485950
Status: COMPLETED
Last Update Posted: 2022-03-15
First Post: 2018-03-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
Sponsor: M.D. Anderson Cancer Center
Organization: